The Most Important Facts About Viatris

By Kim Brooks • Thursday, November 20 15:26 • Permanent Link

Viatris logged a -2.0% change during today's afternoon session, and is now trading at a price of $10.26 per share. The S&P 500 index moved -1.0%. VTRS's trading volume is 4,265,969 compared to the stock's average volume of 9,299,754.

Viatris trades -15.42% away from its average analyst target price of $12.12 per share. The 8 analysts following the stock have set target prices ranging from $9.0 to $15.0, and on average have given Viatris a rating of buy.

If you are considering an investment in VTRS, you'll want to know the following:

Viatris has moved -21.1% over the last year, and the S&P 500 logged a change of 11.7%
Based on its trailing earnings per share of -3.13, Viatris has a trailing 12 month Price to Earnings (P/E) ratio of -3.3 while the S&P 500 average is 29.3
VTRS has a forward P/E ratio of 3.8 based on its forward 12 month price to earnings (EPS) of $2.67 per share
Its Price to Book (P/B) ratio is 0.78 compared to its sector average of 3.19
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Based in Canonsburg, the company has 30,000 full time employees and a market cap of $11.84 Billion. Viatris currently returns an annual dividend yield of 4.6%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.